Verbatim response from Claude
Zepbound vs. Compounded Tirzepatide: Is Brand Worth It?
Quick Answer
It depends on your priorities, but here's an honest breakdown:
Arguments FOR Zepbound (Brand Name)
- Verified quality & consistency – Eli Lilly manufactures to strict FDA standards
- Pen device is convenient – pre-filled, easy to use
- Patient support programs – Lilly's Lilly Cares savings card can bring cost to ~$550/month (or ~$25/month with qualifying insurance)
- Clinical trial data is specifically for this formulation
- Now FDA-approved, so more insurance coverage is possible
Arguments FOR Compounded Tirzepatide
- Significantly cheaper – often $200-$400/month through telehealth companies
- Popular providers: Hims & Hers, Ro, Henry Meds, or local compounding pharmacies
- Useful when Zepbound is unaffordable or unavailable
Important Warnings About Compounding
- FDA has ended the shortage designation for tirzepatide, meaning most compounded versions are now legally questionable
- Quality control varies significantly
- Some providers add B12 or other ingredients with unknown interactions
My Recommendation
If you can access Zepbound at ~$550/month or less through Lilly's savings program, the brand is worth it for peace of mind and consistency. If cost is a genuine barrier, discuss compounding risks carefully with your doctor first.